StocksFin Logo
SAGE logo
$SAGE

Sage Therapeutics, Inc.

SAGE country of incorporation
|
https://www.sagerx.com
|
Dr. Jeffrey Jonas
|
471 employees
NASDAQ | Healthcare | Biotechnology
SAGE reported its Q322 earnings on November 8, 2022 (97 weeks ago).
$1.74M 20.8% vs. Q321 Revenues Q322
89.42% -1.6% vs. Q321 Gross Profit Margin
-1000% ! 0% vs. Q321 Net Profit Margin
-119.23M ! -73.2% vs. Q321 Free Cash Flow Q322
$-2.31 ! -4.5% vs. Q321 EPS Q322
Company Card Q322
As reported on November 8, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B
Growth calculated YoY
Company Card Q322
As reported on November 8, 2022
Is profitable?
Has Revenue Growth?
Has Net Profit Growth?
Has FCF Growth?
Has OCF Growth?
Has EPS Growth?
Pays a Dividend?
Rating
B
Growth calculated YoY
Overview
Income Statement
Full Income Statement
Period Net Revenue Cost of Revenue Net Profit EPS
FY2022 Not reported yet.
Q32022
1.74M
+15.9%
184k
-137.32M
-8.8%
$-2.31
Q22022
1.5M
-5.1%
200k
-126.26M
-3.4%
$-2.13
Q12022
1.58M
286k
-122.06M
$-2.07
FY2021
6.31M
 553k
-457.89M
$-7.8
Q42021
1.64M
+14%
87k
-124.71M
+4.2%
$-2.12
Q32021
1.44M
-12.4%
131k
-130.17M
-21.4%
$-2.21
Q22021
1.64M
+3.8%
148k
-107.25M
-12%
$-1.83
Q12021
1.58M
187k
-95.76M
$-1.64
FY2020
1.11B
 565k
606.07M
$10
FY2019
6.87M
 400k
-680.24M
$-10
FY2018
90.27M
 0
-372.88M
$-8.08
Balance Sheet
Full Balance Sheet
Period Total Assets Total Liabilities Cash & Eq. Debt Stock Equity
FY2022 Not reported yet.
Q32022
1.49B
 105.95M
199.83M
13.77M
1.38B
Q22022
1.6B
 97.14M
206.51M
15.36M
1.5B
Q12022
1.71B
 87.2M
178.67M
16.92M
1.62B
FY2021
1.83B
 96.26M
294.23M
25.9M
1.73B
FY2020
2.16B
 86.91M
1.66B
36.76M
2.07B
FY2019
1.08B
 139.5M
126.71M
0
944.66M
FY2018
952.71M
 89.73M
190.94M
0
862.97M
Cash Flow Statement
Full Cash Flow Statement
Period Operating CF Investing CF Financing CF Capex Free Cash Flow
FY2022 Not reported yet.
Q32022
-118.87M
 110.95M
1.23M
-364k
-119.23M
-11.9%
Q22022
-106.44M
 134.26M
13k
-122k
-106.56M
+1.3%
Q12022
-107.8M
 -9.56M
1.8M
-169k
-107.97M
FY2021
-378.18M
 -1B
13.33M
-372k
-378.55M
FY2020
664.28M
 442.68M
426.76M
-345k
663.94M
FY2019
-528.71M
 -143.16M
607.62M
-5.75M
-534.46M
FY2018
-260.67M
 -512.46M
659.36M
-2.86M
-263.53M
Institutional Ownership
Dividend History
No dividend history.
Number of Employees